Medindia
Medindia LOGIN REGISTER
Advertisement

Largest Long-Term Study Confirms EDAP's Ablatherm® HIFU is Effective, Highly Reproducible Primary Treatment for Localized Prostate Cancer

Tuesday, May 17, 2011 General News
Advertisement
-- 2,552 Patient, International, Multi-Center, 10-year Study Shows 83% of Patients Cancer Free --

Company Contact:

Blandine ConfortInvestor Relations / Legal Affairs+33 4 72 15 31 72[email protected]

Media/Investors:

Kim Muscara/Stephanie Carrington  646-536-7011/7017 [email protected] [email protected]

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close